European life sciences investor LSP has launched the €150m (US$183.1m) LSP Dementia Fund. It will be managed by dementia scientist and thought leader Philip Scheltens. A first of its kind, the LSP Dementia Fund will focus on all stages of dementia drug and medtech development. Its aim to find novel treatments to battle the different…
Home Healthcare Markets International Business Netherlands: LSP and Philip Scheltens launch dementia fund